Eagle Pharmaceuticals Inc (EGRX)
0.95
+0.05
(+5.56%)
USD |
OTCM |
Nov 22, 16:00
Eagle Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 7.99% |
| March 31, 2023 | 8.67% |
| December 31, 2022 | 13.45% |
| September 30, 2022 | -10.82% |
| June 30, 2022 | -12.75% |
| March 31, 2022 | 38.02% |
| December 31, 2021 | -14.64% |
| September 30, 2021 | -14.11% |
| June 30, 2021 | 7.51% |
| March 31, 2021 | -1.02% |
| December 31, 2020 | 16.14% |
| September 30, 2020 | 14.14% |
| June 30, 2020 | -0.61% |
| March 31, 2020 | -6.24% |
| December 31, 2019 | 2.08% |
| September 30, 2019 | -5.81% |
| June 30, 2019 | 11.86% |
| March 31, 2019 | 18.02% |
| December 31, 2018 | 22.46% |
| September 30, 2018 | 27.35% |
| June 30, 2018 | 4.48% |
| March 31, 2018 | 5.61% |
| Date | Value |
|---|---|
| December 31, 2017 | 19.42% |
| September 30, 2017 | 24.49% |
| June 30, 2017 | 8.99% |
| March 31, 2017 | 29.85% |
| December 31, 2016 | 70.62% |
| September 30, 2016 | 31.59% |
| June 30, 2016 | 32.01% |
| March 31, 2016 | -3.03% |
| December 31, 2015 | 6.70% |
| September 30, 2015 | -177.2% |
| June 30, 2015 | -136.2% |
| March 31, 2015 | 54.25% |
| December 31, 2014 | -98.32% |
| September 30, 2014 | -323.9% |
| June 30, 2014 | -50.66% |
| March 31, 2014 | -53.64% |
| December 31, 2013 | -59.27% |
| September 30, 2013 | 10.43% |
| June 30, 2013 | 14.87% |
| March 31, 2013 | -193.6% |
| December 31, 2012 | -167.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-14.64%
Minimum
Dec 2021
38.02%
Maximum
Mar 2022
3.19%
Average
2.08%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Verrica Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |